Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children ; volume:30 ; number:5 ; day:30 ; month:4 ; year:2024 ; pages:1373-1383 ; date:5.2024
Nature medicine ; 30, Heft 5 (30.4.2024), 1373-1383, 5.2024

Creator
Zhong, Youjia
Kang, Alicia Y. H.
Tay, Carina J. X.
Li, Hui’ En
Elyana, Nurul
Tan, Chee Wah
Yap, Wee Chee
Lim, Joey M. E.
Bert, Nina Le
Chan, Kuan Rong
Ong, Eugenia Z.
Low, Jenny G.
Shek, Lynette P.
Tham, Elizabeth Huiwen
Ooi, Eng E.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41591-024-02962-3
URN
urn:nbn:de:101:1-2408191004572.766974026348
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Zhong, Youjia
  • Kang, Alicia Y. H.
  • Tay, Carina J. X.
  • Li, Hui’ En
  • Elyana, Nurul
  • Tan, Chee Wah
  • Yap, Wee Chee
  • Lim, Joey M. E.
  • Bert, Nina Le
  • Chan, Kuan Rong
  • Ong, Eugenia Z.
  • Low, Jenny G.
  • Shek, Lynette P.
  • Tham, Elizabeth Huiwen
  • Ooi, Eng E.
  • SpringerLink (Online service)

Other Objects (12)

Publisher Correction: Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children

Publisher Correction: Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children

SARS-CoV-2 Delta variant isolates from vaccinated individuals

SARS-CoV-2 Delta variant isolates from vaccinated individuals

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases

Pediatric cancer patients vaccinated against SARS-CoV-2—a clinical and laboratory follow-up

Pediatric cancer patients vaccinated against SARS-CoV-2—a clinical and laboratory follow-up

Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon

Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon

Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals

Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals

SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations

SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study

Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study

Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2

Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2

Related objects